Copyright Reports & Markets. All rights reserved.

Global RNA-based Biopharmaceuticals Market Research Report 2018 by Manufacturers, Regions, Types and Applications

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 RNA-based Biopharmaceuticals Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance
      • 2.1.1 Product Type Market Performance (Volume)
      • 2.1.2 Product Type Market Performance (Value)
    • 2.2 China RNA-based Biopharmaceuticals Market Performance
    • 2.3 USA RNA-based Biopharmaceuticals Market Performance
    • 2.4 Europe RNA-based Biopharmaceuticals Market Performance
    • 2.5 Japan RNA-based Biopharmaceuticals Market Performance
    • 2.6 Korea RNA-based Biopharmaceuticals Market Performance
    • 2.7 India RNA-based Biopharmaceuticals Market Performance
    • 2.8 Southeast Asia RNA-based Biopharmaceuticals Market Performance
    • 2.9 South America RNA-based Biopharmaceuticals Market Performance

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
    • 3.2 China RNA-based Biopharmaceuticals Market Performance (Volume)
    • 3.3 USA RNA-based Biopharmaceuticals Market Performance (Volume)
    • 3.4 Europe RNA-based Biopharmaceuticals Market Performance (Volume)
    • 3.5 Japan RNA-based Biopharmaceuticals Market Performance (Volume)
    • 3.6 Korea RNA-based Biopharmaceuticals Market Performance (Volume)
    • 3.7 India RNA-based Biopharmaceuticals Market Performance (Volume)
    • 3.8 Southeast Asia RNA-based Biopharmaceuticals Market Performance (Volume)
    • 3.9 South America RNA-based Biopharmaceuticals Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Pfizer
      • 4.1.1 Pfizer Profiles
      • 4.1.2 Pfizer Product Information
      • 4.1.3 Pfizer RNA-based Biopharmaceuticals Business Performance
      • 4.1.4 Pfizer RNA-based Biopharmaceuticals Business Development and Market Status
    • 4.2 Roche
      • 4.2.1 Roche Profiles
      • 4.2.2 Roche Product Information
      • 4.2.3 Roche RNA-based Biopharmaceuticals Business Performance
      • 4.2.4 Roche RNA-based Biopharmaceuticals Business Development and Market Status
    • 4.3 Sanofi-Aventis
      • 4.3.1 Sanofi-Aventis Profiles
      • 4.3.2 Sanofi-Aventis Product Information
      • 4.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Business Performance
      • 4.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Business Development and Market Status
    • 4.4 Abbott Laboratories
      • 4.4.1 Abbott Laboratories Profiles
      • 4.4.2 Abbott Laboratories Product Information
      • 4.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Business Performance
      • 4.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Business Development and Market Status
    • 4.5 Arrowhead Pharmaceuticals
      • 4.5.1 Arrowhead Pharmaceuticals Profiles
      • 4.5.2 Arrowhead Pharmaceuticals Product Information
      • 4.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Business Performance
      • 4.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Business Development and Market Status
    • 4.6 Benitec Biopharma
      • 4.6.1 Benitec Biopharma Profiles
      • 4.6.2 Benitec Biopharma Product Information
      • 4.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Business Performance
      • 4.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Business Development and Market Status
    • 4.7 Calimmune Inc
      • 4.7.1 Calimmune Inc Profiles
      • 4.7.2 Calimmune Inc Product Information
      • 4.7.3 Calimmune Inc RNA-based Biopharmaceuticals Business Performance
      • 4.7.4 Calimmune Inc RNA-based Biopharmaceuticals Business Development and Market Status
    • 4.8 Dicerna
      • 4.8.1 Dicerna Profiles
      • 4.8.2 Dicerna Product Information
      • 4.8.3 Dicerna RNA-based Biopharmaceuticals Business Performance
      • 4.8.4 Dicerna RNA-based Biopharmaceuticals Business Development and Market Status
    • 4.9 Gradalis
      • 4.9.1 Gradalis Profiles
      • 4.9.2 Gradalis Product Information
      • 4.9.3 Gradalis RNA-based Biopharmaceuticals Business Performance
      • 4.9.4 Gradalis RNA-based Biopharmaceuticals Business Development and Market Status
    • 4.10 Quark
      • 4.10.1 Quark Profiles
      • 4.10.2 Quark Product Information
      • 4.10.3 Quark RNA-based Biopharmaceuticals Business Performance
      • 4.10.4 Quark RNA-based Biopharmaceuticals Business Development and Market Status
    • 4.11 RXi
    • 4.12 Senesco
    • 4.13 Sanofi-Aventis
    • 4.14 Abbott Laboratories
    • 4.15 Arrowhead Pharmaceuticals
    • 4.20 Quark

    5 Market Performance for Manufacturers

    • 5.1 Global RNA-based Biopharmaceuticals Production (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Global RNA-based Biopharmaceuticals Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Global RNA-based Biopharmaceuticals Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Global RNA-based Biopharmaceuticals Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Global RNA-based Biopharmaceuticals Market Performance (Production Point)

    • 6.1 Global RNA-based Biopharmaceuticals Production (K Units) and Market Share by Regions 2013-2018
    • 6.2 Global RNA-based Biopharmaceuticals Revenue (M USD) and Market Share by Regions 2013-2018
    • 6.3 Global RNA-based Biopharmaceuticals Price (USD/Unit) by Regions 2013-2018
    • 6.4 Global RNA-based Biopharmaceuticals Gross Margin by Regions 2013-2018

    7 Development Trend for Regions (Production Point)

    • 7.1 Global RNA-based Biopharmaceuticals Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
    • 7.2 China RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.3 USA RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.4 Europe RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.5 Japan RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.6 Korea RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.7 India RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.8 Southeast Asia RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.9 South America RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

    8 Global RNA-based Biopharmaceuticals Market Performance (Consumption Point)

    • 8.1 Global RNA-based Biopharmaceuticals Consumption and Market Share by Regions 2013-2018
    • 8.2 Global RNA-based Biopharmaceuticals Consumption Value and Market Share by Regions 2013-2018
    • 8.3 Global RNA-based Biopharmaceuticals Price (USD/Unit) by Regions 2013-2018

    9 Development Trend for Regions (Sales Point)

    • 9.1 Global RNA-based Biopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.2 China RNA-based Biopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.3 USA RNA-based Biopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.4 Europe RNA-based Biopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.5 Japan RNA-based Biopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.6 Korea RNA-based Biopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.7 India RNA-based Biopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.8 Southeast Asia RNA-based Biopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.9 South America RNA-based Biopharmaceuticals Sales and Growth, Sales Value and Growth Rate2013-2018

    10 Upstream Source, Technology and Cost

    • 10.1 Upstream Source
    • 10.2 Technology
    • 10.3 Cost

    11 Channel Analysis

    • 11.1 Market Channel
    • 11.2 Distributors

    12 Consumer Analysis

    • 12.1 Cancer Industry
    • 12.2 Diabetes Industry
    • 12.3 Tuberculosis Industry
    • 12.4 Cardiovascular Diseases Industry

    13 Market Forecast 2019-2024

    • 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 13.1.1 Global RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 13.1.2 Global RNA-based Biopharmaceuticals Production (K Units) and Growth Rate 2019-2024
      • 13.1.3 China RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.4 USA RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.5 Europe RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.6 Japan RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.7 Korea RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.8 India RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.9 Southeast Asia RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.10 South America RNA-based Biopharmaceuticals Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.2 Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.1 Global RNA-based Biopharmaceuticals Consumption and Market Share by Regions 2019-2024
      • 13.2.2 Global RNA-based Biopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.3 China RNA-based Biopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.4 USA RNA-based Biopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.5 Europe RNA-based Biopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.6 Japan RNA-based Biopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.7 Korea RNA-based Biopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.8 India RNA-based Biopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.9 Southeast Asia RNA-based Biopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.10 South America RNA-based Biopharmaceuticals Sales, Sales Value and Growth Rate 2019-2024
    • 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
      • 13.3.1 Overall Market Performance
      • 13.3.2 Therapeutics Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3.3 Vaccines Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.4 Sales by Application 2019-2024
      • 13.4.1 Overall Market Performance
      • 13.4.2 Cancer Sales and and Growth Rate 2019-2024
      • 13.4.3 Diabetes Sales and and Growth Rate 2019-2024
      • 13.4.4 Tuberculosis Sales and and Growth Rate 2019-2024
      • 13.4.5 Cardiovascular Diseases Sales and and Growth Rate 2019-2024
    • 13.5 Price (USD/Unit) and Gross Profit
      • 13.5.1 Global RNA-based Biopharmaceuticals Price (USD/Unit) Trend 2019-2024
      • 13.5.2 Global RNA-based Biopharmaceuticals Gross Profit Trend 2019-2024

    14 Conclusion

    Geographically, global RNA-based Biopharmaceuticals market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Pfizer
    Roche
    Sanofi-Aventis
    Abbott Laboratories
    Arrowhead Pharmaceuticals
    Benitec Biopharma
    Calimmune Inc
    Dicerna
    Gradalis
    Quark
    RXi
    Senesco
    Silence Therapeutics
    Silenseed
    Tekmira

    On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
    Therapeutics
    Vaccines
    For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of RNA-based Biopharmaceuticals for each application, including
    Cancer
    Diabetes
    Tuberculosis
    Cardiovascular Diseases
    Others
    Production, consumption, revenue, market share and growth rate are the key targets for RNA-based Biopharmaceuticals from 2013 to 2024 (forecast) in these regions
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now